NO20024590L - Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling - Google Patents

Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling

Info

Publication number
NO20024590L
NO20024590L NO20024590A NO20024590A NO20024590L NO 20024590 L NO20024590 L NO 20024590L NO 20024590 A NO20024590 A NO 20024590A NO 20024590 A NO20024590 A NO 20024590A NO 20024590 L NO20024590 L NO 20024590L
Authority
NO
Norway
Prior art keywords
oligosaccharides
preparation
pharmaceutical preparations
new
preparations containing
Prior art date
Application number
NO20024590A
Other languages
English (en)
Other versions
NO20024590D0 (no
Inventor
Pierre Mourier
Elisabeth Perrin
Christian Viskov
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20024590D0 publication Critical patent/NO20024590D0/no
Publication of NO20024590L publication Critical patent/NO20024590L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Materials Engineering (AREA)
NO20024590A 2000-03-28 2002-09-25 Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling NO20024590L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0003910A FR2807043B1 (fr) 2000-03-28 2000-03-28 Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation
PCT/FR2001/000903 WO2001072762A1 (fr) 2000-03-28 2001-03-26 Compositions pharmaceutiques contenant des oligosaccharides et leur preparation

Publications (2)

Publication Number Publication Date
NO20024590D0 NO20024590D0 (no) 2002-09-25
NO20024590L true NO20024590L (no) 2002-09-25

Family

ID=8848572

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024590A NO20024590L (no) 2000-03-28 2002-09-25 Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling

Country Status (27)

Country Link
EP (1) EP1272499B1 (no)
JP (1) JP2003529570A (no)
KR (1) KR20030001394A (no)
CN (1) CN1183149C (no)
AR (1) AR034251A1 (no)
AT (1) ATE290543T1 (no)
AU (1) AU782713B2 (no)
BR (1) BR0109617A (no)
CA (1) CA2403906A1 (no)
DE (1) DE60109279T2 (no)
EA (1) EA004768B1 (no)
EE (1) EE200200551A (no)
ES (1) ES2236206T3 (no)
FR (1) FR2807043B1 (no)
HK (1) HK1056564A1 (no)
HU (1) HUP0300330A3 (no)
IL (1) IL151832A0 (no)
ME (1) MEP88408A (no)
MX (1) MXPA02009455A (no)
NO (1) NO20024590L (no)
NZ (1) NZ521558A (no)
PL (1) PL204419B1 (no)
PT (1) PT1272499E (no)
SK (1) SK286745B6 (no)
WO (1) WO2001072762A1 (no)
YU (1) YU72802A (no)
ZA (1) ZA200207707B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750207B1 (en) * 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US7511026B2 (en) * 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US20050186679A1 (en) * 2004-02-24 2005-08-25 Christian Viskov Method for determining specific groups constituting heparins or low molecular weight heparins
JP5116071B2 (ja) 2005-07-20 2013-01-09 帝國製薬株式会社 Ｄ−アロースおよびｄ−プシコースの抗神経因性疼痛効果の利用
WO2007026485A1 (ja) 2005-08-30 2007-03-08 Inter-University Research Institute Corporation National Institutes Of Natural Sciences ユニバーサル塩基
EP3418287A1 (en) * 2017-06-21 2018-12-26 Universität für Bodenkultur Wien Chemical release of asparaginelinked glycans
CN115317507A (zh) * 2022-09-19 2022-11-11 中国科学院海洋研究所 低分子量褐藻多糖硫酸酯在制备抗多动症药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases

Also Published As

Publication number Publication date
DE60109279T2 (de) 2006-04-13
MXPA02009455A (es) 2003-02-12
PL357301A1 (en) 2004-07-26
CN1426419A (zh) 2003-06-25
PT1272499E (pt) 2005-06-30
ES2236206T3 (es) 2005-07-16
CA2403906A1 (fr) 2001-10-04
PL204419B1 (pl) 2010-01-29
HUP0300330A2 (hu) 2003-06-28
EE200200551A (et) 2004-04-15
NO20024590D0 (no) 2002-09-25
KR20030001394A (ko) 2003-01-06
YU72802A (sh) 2006-01-16
FR2807043B1 (fr) 2002-11-22
FR2807043A1 (fr) 2001-10-05
EP1272499A1 (fr) 2003-01-08
CN1183149C (zh) 2005-01-05
NZ521558A (en) 2005-10-28
HK1056564A1 (en) 2004-02-20
AR034251A1 (es) 2004-02-18
EA004768B1 (ru) 2004-08-26
AU782713B2 (en) 2005-08-25
HUP0300330A3 (en) 2003-09-29
DE60109279D1 (de) 2005-04-14
WO2001072762A1 (fr) 2001-10-04
MEP88408A (en) 2011-12-20
BR0109617A (pt) 2003-02-04
EA200201024A1 (ru) 2003-02-27
ZA200207707B (en) 2003-12-24
SK13932002A3 (sk) 2003-06-03
SK286745B6 (sk) 2009-04-06
EP1272499B1 (fr) 2005-03-09
IL151832A0 (en) 2003-04-10
JP2003529570A (ja) 2003-10-07
ATE290543T1 (de) 2005-03-15
AU4663901A (en) 2001-10-08

Similar Documents

Publication Publication Date Title
NO20032187L (no) Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene
NO982580D0 (no) Nye taxoider, deres fremstilling samt farmas°ystiske preparater inneholdende taxoidene
NO20024176L (no) Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
NO20010013D0 (no) Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
NO20032438D0 (no) Orto- og metasubstituerte bis-arylforbindelser, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
NL1015859A1 (nl) Farmaceutische preparaten.
NO20030296L (no) Heparinavledede polysakkaridblandinger, deres fremstilling samt farmasöytiske preparater inneholdende blandingene
NO20005146L (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
NO992102D0 (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
DK1098874T3 (da) Benzocycloheptener, fremgangsmåder til deres fremstilling, farmaceutiske præparater, som indeholder disse, samt deres anvendelse til fremstilling af lægemidler
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
NO995745D0 (no) Nye derivater av erytromycin, fremgangsmåte for fremstilling av disse, samt deres anvendelse som medikamenter
NO20016247L (no) Streptograminderivater, deres fremstilling samt preparater inneholdende derivatene
NO20041773L (no) Farmasoytiske preparater for reduksjon av cellers aktivitet samt deres anvendelse.
NO20003661L (no) Nye pentasakkarider, fremgangsmÕter for deres fremstilling og farmasøytiske preparater inneholdende de samme
NO20024590L (no) Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling
DK1118610T3 (da) Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
NO983472D0 (no) Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
NO20035163D0 (no) Nye piperidinkarboksamid-derivater, fremgangsmåte for deres fremstilling ogfarmasöytiske preparater inneholdende de samme
DK199900435U3 (da) Farmaceutisk præparat omfattende paroxetin-methansulfonat samt anvendelse heraf
NO20014692L (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
NO985171L (no) Sulfonamidsubstituerte kondenserte 5-ringforbindelser, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO20025028D0 (no) 9-oksa-epotilonderivater, fremgangsmåte for fremstilling derav samt deres anvendelse i farmasöytiske preparater